Kenneth W. To

Sar, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Development and clinical application of a primary cancer organoid-PBMC co-culture system for personalized immunotherapy.

Development and clinical application of a primary cancer organoid-PBMC co-culture system for personalized immunotherapy.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: March 15, 2026

Treatment sequences of a phage and colistin combination trigger different evolution pathways of a multidrug-resistant Acinetobacter baumannii yielding distinct treatment outcomes.

Treatment sequences of a phage and colistin combination trigger different evolution pathways of a multidrug-resistant Acinetobacter baumannii yielding distinct treatment outcomes.

Journal: International journal of antimicrobial agents

Published: June 16, 2025

Nanoengineered-based delivery systems to modulate CD4+ T cell responses in cancer: emerging paradigms in cancer immunotherapy.

Nanoengineered-based delivery systems to modulate CD4+ T cell responses in cancer: emerging paradigms in cancer immunotherapy.

Journal: Frontiers in pharmacology

Published: June 09, 2025

Recent Advances in the Use of Ganoderma lucidum and Coriolus versicolor Mushrooms to Enhance the Anticancer Efficacy of EGFR-Targeted Drugs in Lung Cancer.

Recent Advances in the Use of Ganoderma lucidum and Coriolus versicolor Mushrooms to Enhance the Anticancer Efficacy of EGFR-Targeted Drugs in Lung Cancer.

Journal: Pharmaceutics

Published: May 31, 2025

Correction: Intra-tumoral sphingobacterium multivorum promotes triple-negative breast cancer progression by suppressing tumor immunosurveillance.

Correction: Intra-tumoral sphingobacterium multivorum promotes triple-negative breast cancer progression by suppressing tumor immunosurveillance.

Journal: Molecular cancer

Published: January 28, 2025

Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy.

Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 17, 2025

Effect of Extracellular Vesicles Derived From Tumor Cells on Immune Evasion.

Effect of Extracellular Vesicles Derived From Tumor Cells on Immune Evasion.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 21, 2024

Resistance to antibody-drug conjugates: A review.

Resistance to antibody-drug conjugates: A review.

Journal: Acta pharmaceutica Sinica. B

Published: November 20, 2024

Intra-tumoral sphingobacterium multivorum promotes triple-negative breast cancer progression by suppressing tumor immunosurveillance.

Intra-tumoral sphingobacterium multivorum promotes triple-negative breast cancer progression by suppressing tumor immunosurveillance.

Journal: Molecular cancer

Published: August 09, 2024

Serum creatine kinase elevation following tyrosine kinase inhibitor treatment in cancer patients: Symptoms, mechanism, and clinical management.

Serum creatine kinase elevation following tyrosine kinase inhibitor treatment in cancer patients: Symptoms, mechanism, and clinical management.

Journal: Clinical and translational science

Published: June 16, 2024

PBA2, a novel inhibitor of the β-catenin/CBP pathway, eradicates chronic myeloid leukemia including BCR-ABL T315I mutation.

PBA2, a novel inhibitor of the β-catenin/CBP pathway, eradicates chronic myeloid leukemia including BCR-ABL T315I mutation.

Journal: Molecular cancer

Published: June 07, 2024

Competing endogenous RNAs (ceRNAs) and drug resistance to cancer therapy.

Competing endogenous RNAs (ceRNAs) and drug resistance to cancer therapy.

Journal: Cancer drug resistance (Alhambra, Calif.)

Published: May 24, 2024

Showing 1-12 of 57

Last Updated: 09/26/2026